Osteogenesis Imperfecta Type 4

Disease Overview

Osteogenesis Imperfecta (OI) Type 4 is a moderately severe genetic disorder characterized by bone fragility, resulting in bones that break easily, often from mild trauma or with no apparent cause. Patients typically have normal or near-normal stature and experience a variable range of clinical manifestations.

Disease Category

Genetic disorder Bone metabolism disorder Connective tissue disorder

Synonyms

• OI Type IV
• Osteogenesis Imperfecta Type IV
• Brittle Bone Disease (general term)

Signs & Symptoms

• Frequent bone fractures
• Moderate bone fragility
• Normal to near-normal sclera
• Short stature
• Mild to moderate long bone deformities
• Possible dentinogenesis imperfecta
• Potential hearing loss in adulthood
• Joint hypermobility
• Reduced bone density
• Possible spinal curvature (scoliosis)

Causes

Genetic mutations: - Autosomal dominant inheritance pattern - Mutations in COL1A1 or COL1A2 genes - Defective type I collagen production - Impaired bone matrix formation - Reduced bone mineral density

Affected Populations

• Prevalence: 1 in 20,000 to 1 in 50,000 live births
• Affects all ethnic backgrounds
• Equal gender distribution
• Can occur in any family lineage

Disorders with Similar Symptoms

• Other Osteogenesis Imperfecta types
• Ehlers-Danlos syndrome
• Hypophosphatasia
• Rickets
• Achondroplasia
• Marfan syndrome

Diagnosis

Diagnostic methods: - Comprehensive clinical evaluation - Detailed family medical history - Radiological imaging - Bone density scans - Genetic testing - Biochemical collagen analysis - Skin or bone biopsy

Standard Therapies

• Pharmacological treatments
  • Bisphosphonates
  • Calcium and vitamin D supplements
• Physical therapy
• Orthopedic interventions
• Surgical bone stabilization
• Mobility assistive devices
• Pain management
• Regular orthopedic monitoring

Clinical Trials and Studies

• Ongoing research in:
  • Gene therapy
  • Stem cell treatments
  • Advanced pharmacological interventions
• Recommended resources:
  • ClinicalTrials.gov
  • National Institutes of Health (NIH)
  • Osteogenesis Imperfecta Foundation research programs

References

• National Institutes of Health
• Genetics Home Reference
• Osteogenesis Imperfecta Foundation
• Recent peer-reviewed medical journals

Programs & Resources

• Osteogenesis Imperfecta Foundation (OIF)
• National Organization for Rare Disorders (NORD)
• Genetic and Rare Diseases Information Center (GARD)
• Patient support groups
• Online medical resources

Complete Report

A comprehensive medical document detailing the clinical, genetic, and management aspects of Osteogenesis Imperfecta Type 4, designed for patients, healthcare professionals, and researchers seeking in-depth understanding of this rare genetic condition.